Sedation for Brain Magnetic Resonance Imaging in Preterm Infants: Using Propofol under Anesthesiologist Supervision
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We aimed to compare two different sedation protocols for brain magnetic resonance imaging (MRI) in preterm infants. One protocol used chloral hydrate (CH) with monitoring conducted by non-anesthesiologists, and the other used a continuous infusion of propofol (PF) with monitoring by anesthesiologists. Methods: A total of 250 preterm infants born between January 2011 and December 2015 who received brain MRI during hospitalization in our neonatal intensive care unit (NICU) were included in this retrospective study. In period 1, sedation for brain MRI was done using a single dose or multiple doses of CH with monitoring conducted by NICU medical staff. In period 2, an anesthesiologist prescribed a continuous infusion of PF and titrated the dosage for minimal and adequate sedation. Data on the adverse events, including desaturation and bradycardia, were collected and compared between periods 1 and 2. Results: Despite similar gestational ages of the patients in periods 1 and 2, the infants in period 1 showed a higher risk of developing bradycardia after sedation compared to those in period 2 (30.2% vs. 14.8%; an adjusted odds ratio of 2.35; 95% confidence interval of 1.12 to 4.91). Infants who had an adverse event after sedation had a lower gestational age and corrected age at the time of MRI (26.8 weeks vs. 27.9 weeks, P=0.004; 37.3 weeks vs. 38.3 weeks, P=0.023). The duration of MRI was significantly longer in infants that had an adverse event than those that did not (70.9 minutes vs. 64.3 minutes). After adjusting for various clinical factors, lower gestational age, lower corrected age at the time of MRI, and period 1 increased the risk of developing adverse events after sedation for MRI. Conclusion: The use of a continuous PF infusion with dose titration and monitoring by an anesthesiologist is safe and feasible as a sedation protocol for brain MRI in prematurely born infants.
Abstract
Purpose: We aimed to compare two different sedation protocols for brain magnetic resonance imaging (MRI) in preterm infants. One protocol used chloral hydrate (CH) with monitoring conducted by non-anesthesiologists, and the other used a continuous infusion of propofol (PF) with monitoring by anesthesiologists. Methods: A total of 250 preterm infants born between January 2011 and December 2015 who received brain MRI during hospitalization in our neonatal intensive care unit (NICU) were included in this retrospective study. In period 1, sedation for brain MRI was done using a single dose or multiple doses of CH with monitoring conducted by NICU medical staff. In period 2, an anesthesiologist prescribed a continuous infusion of PF and titrated the dosage for minimal and adequate sedation. Data on the adverse events, including desaturation and bradycardia, were collected and compared between periods 1 and 2. Results: Despite similar gestational ages of the patients in periods 1 and 2, the infants in period 1 showed a higher risk of developing bradycardia after sedation compared to those in period 2 (30.2% vs. 14.8%; an adjusted odds ratio of 2.35; 95% confidence interval of 1.12 to 4.91). Infants who had an adverse event after sedation had a lower gestational age and corrected age at the time of MRI (26.8 weeks vs. 27.9 weeks, P=0.004; 37.3 weeks vs. 38.3 weeks, P=0.023). The duration of MRI was significantly longer in infants that had an adverse event than those that did not (70.9 minutes vs. 64.3 minutes). After adjusting for various clinical factors, lower gestational age, lower corrected age at the time of MRI, and period 1 increased the risk of developing adverse events after sedation for MRI. Conclusion: The use of a continuous PF infusion with dose titration and monitoring by an anesthesiologist is safe and feasible as a sedation protocol for brain MRI in prematurely born infants.
참고문헌 (23)
- Slaughter LA, "Early conventional MRI for prediction of neurodevelopmental impairment in extremely-low-birth-weight infants", Neonatology, 110, pp.47~54 (2016)
- Pennock JM, "MRI of the neonatal brain", pp.3~15 (2002), W.B. Saunders
- Hall RW, "Drugs of choice for sedation and analgesia in the neonatal ICU", Clin Perinatol, 36, pp.15~26 (2009)
- Litman RS, "Chloral hydrate sedation in term and preterm infants : an analysis of efficacy and complications", Anesth Analg, 110, pp.739~746 (2010)
- Finnemore A, "Chloral hydrate sedation for magnetic resonance imaging in newborn infants", Paediatr Anaesth, 24, pp.190~195 (2014)
- Pershad J, "Chloral hydrate : the good and the bad", Pediatr Emerg Care, 15, pp.432~435 (1999)
- Rigby-Jones AE, "Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit", Anesthesiology, 97, pp.1393~1400 (2002)
- Machata AM, "Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging", Br J Anaesth, 101, pp.239~243 (2008)
- Pershad J, "Comparison of propofol with pentobarbital", midazolam, Pediatrics, pp.2007, 120[DOI]
- Arthurs OJ, "Anaesthesia or sedation for paediatric MRI : advantages and disadvantages", Curr Opin Anaesthesiol, 26, pp.489~494 (2013)
- Allegaert K, "Pharmacodynamics of chloral hydrate in former preterm infants", Eur J Pediatr, 164, pp.403~407 (2005)
- Smallman B, "Pediatric sedation : can it be safely performed by non-anesthesiologists", Curr Opin Anaesthesiol, 15, pp.455~459 (2002)
- Chiaretti A, "Safety and efficacy of propofol administered by paediatricians during procedural sedation in children", Acta Paediatr, 103, pp.182~187 (2014)
- Krauss BS, "Procedural sedation and analgesia in children", N Engl J Med, 371, pp.91~ (2014)
- Cook-Sather SD, "Modern fasting guidelines in children", Best Pract Res Clin Anaesthesiol, 20, pp.471~481 (2006)
- 최영석, "소아 환자의 진정을 위한 chloral hydrate의 효과", 대한소아신경학회지, 16(1), pp.78~85 (2008), 대한소아신경학회
- Delgado J, "Chloral hydrate in pediatric magnetic resonance imaging : evaluation of a 10-year sedation experience administered by radiologists", Pediatr Radiol, 45, pp.108~114 (2015)
- Allegaert K, "The clinical pharmacology of short acting analgosedatives in neonates", Curr Clin Pharmacol, 6, pp.222~226 (2011)
- Welzing L, "Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates", Paediatr Anaesth, 20, pp.605~611 (2010)
- Dalal PG, "Sedation and anesthesia protocols used for magnetic resonance imaging studies in infants : provider and pharmacologic considerations", Anesth Analg, 103, pp.863~868 (2006)
- Cravero JP, "Incidence and nature of adverse events during pediatric sedation", anesthesia for procedures outside the operating room : report from the pediatric sedation research consortium, 2006, pp.118, 1087~1096
- Allegaert K, "Inter-individual variability in propofol pharmacokinetics in preterm and term neonates", Br J Anaesth, 99, pp.864~870 (2007)
- Havidich JE, "Preterm versus term children : analysis of sedation", anesthesia adverse events and longitudinal risk, 2016, pp.137, e20150463~